Summary: The assay of myelin basic protein in body fluids has potential clinical importance as a routine indicator of demyelination.
Introduction
titre plates, the current batches of these cuvettes show a phenomenon termed the 'smile effect' i.e. the end Myelin basic protein is nervous system specific and the wdb Qn each $trip giye highef readings than those ta the major protein component of myelin (1) . As such it is an centre ideal substance to assay in body fluids as a measure of " j «. A . t_ * , t,™,* ^^ The effect of this on the myehn basic protein assay can demyelination. Such measurements may have applica-*" m * r J , . . , , . . , , A i«. lV% i e c-w^cic he overcome by arranging the replicates of each sample tion to head mmry, stroke and multiple sclerosis * ° ™ . j · _ · , v /9 ö\ in a pemwted distribution. The system as described here pa len s ^ ,, ).
would allow any laboratory to do routine myelin basic We have recently described the principle of an Enzyme pro tein assays. Linked Immunoassay procedure 1 ) for myelin basic protein which offers certain advantages over radioimmunoassay as a routine tool (4) . We show here that Materials md Methods the assay can be applied to plasma and describe some useful data processing procedures.
Gilford immunoassay cuvettes (lot number 1 02592) were obr tained from Gilford Instruments Inc., Ohio. Logit-log graph We also report our experience with Gilford immunoassay paper was obtained from Heffers Bookshop, Cambridge, U.K. cuvettes as a solid phase. Although preferable to microThe E USA f or myelin basic protein was carried out essentially as described previously (4) for use in microtitre plates. It was necessary with the Gilford cuvettes to use 0.25 ml volumes of : ELISA -Enzyme LinKed "«adsorbent £, ^^^^^^' ** * """ Assay.
Groome: Plasma myeiin basic protein assay Coating of wells with antigen A solution of bovine myeiin basic protein at 0.3 mg/1 in 0.1 mol/1 phosphate buffer pH 6.0 was prepared in a siliconised beaker. Bovine myeiin basic protein is used instead of human myeiin basic protein for coating since it is easier to obtain in a highly purified state. 0.25 ml was placed in each cuvette and the cuvette strips stood overnight at 25 °C in a moist atmosphere. The cuvette strips were then washed 10 ÷ with wash solution (12 g/1 sodium chloride, 0.5 g/1 Tween 80), leaving them for 2 h in the last wash to allow loosely bound myeiin basic protein to detach (5). They were then given a distilled water rinse and allowed to air dry. Cuvette strips were then stored over silica gel until required.
Preparation of plasma samples for assay Fresh citrated blood samples were centrifuged to obtain plasma. These were either analysed immediately or stored at -20 °C (6) . Each plasma sample was mixed with one volume of 0.2 mol/1 citrate buffer pH 3.7 and a further volume of 0.05 mol/1 phosphate buffer pH 7.0 containing 12 g/1 sodium chloride, 0.5 g/1 Tween 80 and 0.25 g/1 calf thymus histones. The solution was then heated at 100 °C for 5 minutes, during which time the bulk of the plasma protein precipitates. Myelin basic protein is left quantitatively in solution (6) . After centrifugation the supernatant was used for ELISA.
Procedure

ELISA Stage 1
A control sample was prepared by mixing equal volumes of the supernatant from pooled normal human plasma with a 1:160000 dilution of a rabbit anti-human myeiin basic protein serum (kk42). Antiserum dilution was made in 0.2 mol/1 disodium hydrogen phosphate containing 12 g/1 sodium chloride, 0.5 g/1 Tween 80 and 0.5 g/1 calf thymus histones. This serum reacts well with human and bovine myeiin basic protein. Histones are always added to the buffers immediately before use to prevent the development of inhibitory activity (6) . The standard curve was prepared by adding known amounts of human myeiin basic protein (courtesy ofM. Kies) to pooled normal human plasma. Samples were citrated and boiled and mixed with antiserum as for the control. A blank was prepared by mixing an equal volume of the supernatant from treated normal plasma with buffer alone. The solutions were allowed to stand at room temperature for 4 h before the next stage.
ELISA Stage 2 (as finally adopted) Twenty 0.4 ml aliquots of the control mixture were placed in a permuted distribution in ten cuvette strips occupying the position labelled A and B as in table 2. Ten aliquots of each of the standards occuped positions C, D, E, F, G, H and I and ten aliquots of blank occupied J. The reasons for adopting this permuted distribution are described in a later section. The cuvette strips were then placed in a moist box overnight at room temperature on a device providing slight agitation.
ELISA Stage 3
The cuvette strips were emptied by shaking and then washed 10 X with wash solution. To remove the last traces of liquid they were struck firmly several times onto paper towelling. 0.25 ml of goat anti rabbit-IgG/peroxidase conjugate at a dilution of 1:5000 in conjugate dilution buffer (4) was then added. This was allowed to react for 6 h at room temperature with the cuvettes in a moist box, again with slight agitation.
ELISA Stage 4
The cuvette strips were washed and emptied as before. Then 0.25 ml of peroxidase substrate (4) was added and incubation carried out overnight at room temperature with agitation. The experiments reported here all used 0.1 mol/1 phosphate buffer pH 7.0 as reaction buffer (4). Recently we have found that faster rates of reaction can be achieved in 0.1 mol/1 citrate buffer pH 4.0, other conditions remaining the same.
E LISA Stage 5
The optical faces of the cuvette strips were wiped with tissue and the absorbance at 420 nm at all positions measured with a Gilford cuvette reader referenced to air.
ELISA Stage 6'
The ten absorbance values for each cuvette strip at a time were typed into a computer, which then carries out the following routine calculations: 1. Calculates the average of the A's, B's, C's etc. from the permuted distribution. 2. Subtracts the blank. 3. Averages A and B and designates this the 100% level, in the absence of a competitor. 4. Expresses the average of C, D, E etc. as a % of the control.
Dose interpolation
Linearisation of the standard* curve could be obtained by plotting (% of the control) versus myeiin basic protein concentration on Logit log graph paper. Alternatively the data were fitted by computer to a three parameter non-linear equation by regression analysis (7). The latter method was used routinely.
Procedure for unknown samples Plasma samples containing unknown amounts of myeiin basic protein were citrated and boiled as for the standard curve. For each eight samples to be analysed ten strips are required in addition to those for the standard curve. Positions A arid B are again used for controls but now all eight remaining positions (C-J) are used for unknowns. The (% of the control) for each unknown is calculated and the corresponding myeiin basic protein concentration calculated from the previously determined regression equation.
Results
A 3 competitive ELISA
The A 3 competitive assay principle (8) has not been widely used. A similar assay to that described here has, however, been applied to factor VIII related antigen (9) , although this was of much lower sensitivity. The assay principle is shown in figure 1 . Full details of the initial development of the assay for myeiin basic protein have been described elsewhere (4) .
Adaptation of the ELISA method to use Gilford cuvettes
This required few changes from the method using microtitration plates (4) . A minimum volume of 0.25 ml was used to avoid meniscus effects and to cover the optical path for the final absorbance measurement. Figure 2 shows some of the results of an myeiin basic protein assay in which all ten positions oil a separate strip were used to replicate each dose level. The replicates within one strip did not give values randomly distributed about a mean but a characteristic pattern of reactivity with a central trough. Quality control procedures on Gilford cuvettes are claimed to be rigorous and do predict this phenomenon termed the 'smile' effect (w). The magnl· tude of the smile effect may well vary according to the nature of the absorbed material and the principle of the particular immunoassay. It should be noted that Gilford cuvettes are designed for use in an automated processor
Competitive, heterogenous method for detection of antigen
Step 1 eag I7=a Well is coated with known amount of antigen.
Step 2
StepS
Step 4
Sample antigen and specific antibody are added. Bound and free antigen compete for antibody. Bound and free complexes are separated by washing.
Enzyme-labelled antiglobulin is added and binds to antibody. Free conjugate is removed by washing.
Chromogenic substrate is added. The optical density is reduced in proportion to the amount of competing antigen.
A standard curve is prepared of a range of competing antigen concentrations. The concentration of an unknown sample antigen is determined from the standard curve. (PR50) so that random errors due to variations in the washing treatments and reagent additions will be somewhat greater in the present study than if the whole assay was automated. Nevertheless, many workers will require to use these cuvettes as they are here and will presumably find these results more typical.
Further characterisation of the smile effect
To define more precisely the reactivity of the different cuvette positions in this assay the following experiment was done. Fifteen strips were coated identically with myelin basic protein and were then reacted with anti myelin basic protein serum, exactly as in the control for figure 2. The assay was then completed. The results suggested that the smile was slightly lop-sided ( fig. 3 , tab. 1).
Furthermore, considerable variation occurred in corresponding well positions from strip to strip. The end positions were more variable than the others. This variation could have two components (1) random error (2) systematic error due to variations in the mean from strip to strip. The latter could have two causes. Either variation in experimental strip handling or manufacturing differences. The data of table 1 supported the idea that systematic variation was the major cause, of betweenstrip variability since it can be seen that some strips gave high values at all positions (e.g. marked o), whilst others gave low values at all positions (e.g. marked o).
Attempts to minimise strip to strip variation
Since the initial experiments shown in figure 3 and table 1 were done efforts have been made to make the washing procedures more reproducible. Although these slightly reduced the systematic variation from strip to strip they did not eliminate it. Thus, consideration was given as to the best method of using these cuvette strips to allow the most reliable comparisons between samples. Tab. 1. Actual data (absorbance at 420 nm) for ten of the cuvette strips used for Fig. 3 .
• = strips giving high values at all positions ï = strips giving lower values The data also show the permutation system used to derive a mean in a way which cancels out the smile effect. 
A procedure for using the Gilford cuvettes for precise sample comparisons
Before the myelin basic protein assay could be used with confidence for the routine analysis of clinical samples several questions needed to be considered. Firstly, what level of confidence was required in the percentages of the control value determined at each dose level? Secondly, how many replicates were required to achieve this degree of confidence? Thirdly, how were the replicates at each dose level to be distributed? It was decided that the precision would be adequate if an absorbance 7% below the control level was significant at the 95% confidence level. The distribution of sample replicates was critically important for this standard to be met. If the replicates (e.g. N = 5) at each dose level were all arranged on a single strip the smile effect would cause the two halves of the strip to differ to start with. If the whole strip was used for ten replicates, although the smile effect was overcome, the assay then became unduly sensitive to systematic differences between strips caused by handling or manufacturing differences. It was not justifiable to assume that the standard deviation of SD (within strip) strip means = ----. The SD (within strip) is largely caused by the smile effect and does not allow one to assess the magnitude of between strip variation.
Another possible arrangement would place all the replicates of one sample in well position 1 on a series of strips, and the other samples in positions 2, 2,2, 3,3,3, etc. This arrangement would also allow the distortion of the assay results by the smile effect.
A logical solution to the problem posed above would be to permute the sample replicates as shown in table 2. Early results soon confirmed that samples could be very precisely and unambiguously compared by this method. The standard deviation of permuted sample means within a ten strip array has a standard deviation of about 2.5% (tab. 1). The following procedure has now been adopted routinely for the analysis of unknown. Ten strips are used for two controls (set A and set B) seven standards (C-I) and one blank (J). Each successive ten strips also contain two controls but now have unknown samples at all the remaining positions. A simple computer programme analyses the data in the following way: 1) Absorbance values are requested strip by strip for each batch often strips.
2) The mean of the permuted replicates for A, B, C, etc. is calculated.
3) The blank is subtracted. The practice of having controls on the plate with each batch of standards and unknowns gives the assay a high degree of robustness and thus enhances the confidence which can be placed in unknown values. This is particularly important when large numbers of samples are being analysed. Table 2 shows the data obtained from an experiment which used ten cuvette strips to generate a standard curve for the myelin basic protein assay. Table 1 shows the data obtained on another occasion when all ten sample positions were used for controls. The parameter which was to be calculated for each sample i.e. mean value for sample Snean value for controls is the ratio of two values each with different error. The CV of the ratio can be calculated from statistical theory as 2,4 2 L6y )2 = ' J OO Thus any sample which in a given 10 X 10 array gave a value less than 94% of the mean of the controls would be significantly different from the control (p =? 0.05).
Assay of myelin basic protein in plasma
The detection limit of the assay shown in figure 4 and table 2 is therefore around 1.5 ìg/l of plasma.
Estimation of error in unknown values
Since the response parameter (% of control) has a CV of approx. 3% its valu'e for each unknown will have 95% confidence limits 6% above and 6% below the actual Value. The estimated maximum (p -0.05) minimum (p = 0.05) and mean myelin basic protein concentration were then determined, for each unknown, from the standard curve. Because of the shape of the dose response relationship the upper and lower confidence limits on unknown myelin basic protein concentrations were not symmetrical about the mean. Figure 4 shows a direct plot of (% of control) versus myelin basic protein concentration from the data of table 2. Figure 5 shows the same data plotted on Logitlog graph paper. Good linearisation was found from 2-60 ìg/l myelin basic protein. 
Dose interpolation
Discussion
Enzyme linked immunoadsorbent assays based on antigen adsorption to polystyrene can be used for antigen and antibody assay using a variety of different principles (8) . However, any worker who has tried quantitative ELISA's using microtitre plates will be familiar with the frustrating problems of achieving long term consistency of results.
It has been shown that wells near the edges of the plates often give abnormally high readings and that there is often a non random distribution of readings within the plate (10, 11) . Between batch variability can be considerable as the manufacturers quality control procedures rarely include tests of protein binding (11) . Selection of an acceptable batch of microtitre plates (10) is complicated by the fact that manufacturers may occasionally pool batches for distribution. attempted to divert attention from these shortcomings by developing sophisticated plate washers and through the plate reading photometers. These do not compensate for the above defects which stem from the difficulty of moulding large polystyrene structures reproducibly. Gilford Instruments have recently developed a polystyrene cuvette system which serves first as a solid phase adsorbent and later as an optical cuvette for absorbance measurements. A simple manual reader for these cuvettes and a fully automated sample processor (PR50) for all the stages of ELISA are also available. A high standard of quality control is claimed for the cuvettes and each batch is tested for its protein binding characteristics.
We have found these cuvettes convenient to use. However, the 'smile* effect phenomenon described here does detract from the simplicity of their usage. It means that a permuted distribution of ten sample replicates is the only logical arrangement. However, since in microtitre plates there is no logical way to arrange replicates the Gilford cuvettes are, in our view, a significant improvement. The 'smile' effect is believed to be due to temperature gradients which arise in each curvette strip during moulding. It is probable that its magnitude will be significantly reduced in future batches of the cuvettes. Some assay types seem to give a more marked 'smile' than others (Groome, unpublished) . The ELISA for plasma myelin basic protein works well and has several advantages over radioimmunoassay as a possible routine tool in neuropathology (4) . The acid extraction procedure ofDelassalle et al. (6) is valuable and removes many irrelevant plasma components. These can sometimes interfere with ELISA's on low dilution of serum or plasma (12) .
Workers interested in the future developments in ELISA methodology should note that it is also possible to adsorb antigens to polystyrene spheres or couple them covalently to nylon (13). ELISA's based on such solid phase supports may overcome the disadvantages of the currently available moulded polystyrene formats in providing a randomly distributed binding capacity.
